PDR - PROLIFERATIVE DIABETIC RETINOPATHY

Clinical trials for PDR - PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.

Never miss a new study

Get alerted when new PDR - PROLIFERATIVE DIABETIC RETINOPATHY trials appear

Sign up with your email to follow new studies for PDR - PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Could a daily pill replace eye injections for diabetic retinopathy?

Disease control Completed

This study tested an oral medication called APX3330 in 103 adults with diabetic retinopathy, a leading cause of vision loss. The pill aims to reduce inflammation and low-oxygen damage in the eye. Researchers measured whether it could improve the severity of the disease over 24 we…

Matched conditions: PDR - PROLIFERATIVE DIABETIC RETINOPATHY

Phase: PHASE2 • Sponsor: Ocuphire Pharma, Inc. • Aim: Disease control

Last updated Jun 23, 2026 11:56 UTC

PDR - PROLIFERATIVE DIABETIC RETINOPATHY

Get alerted when new PDR - PROLIFERATIVE DIABETIC RETINOPATHY trials appear

Could a daily pill replace eye injections for diabetic retinopathy?